临床试验/NCT05875636

NCT05875636招募中不适用

GLP-1 Receptor Agonist Use and Incidence of Retained Gastric Food on Endoscopy

Medical University of South Carolina1 个研究点分布在 1 个国家目标入组 260 人开始时间: 2023年8月21日最近更新: 2024年4月30日

适应症

试验速览

阶段: 不适用
状态: 招募中
发起方: Medical University of South Carolina
入组人数: 260
试验地点: 1
主要终点: Retained gastric food

研究概览研究设计入排标准结局指标研究者研究点记录与标识符相似试验

研究概览

简要总结

This study will enroll patients ages 18 and over who are in one of the following groups 1) taking a GLP-1 receptor agonist medication 2) not taking a GLP-1 receptor agonist (control group), are undergoing EGS and have appropriately fasted. Study data will be collected in the form of qualitatively observing whether the stomach is empty as expected, or contains solid or clinically relevant liquid contents.

研究设计

研究类型: Observational
观察模型: Case Control
时间视角: Prospective

入排标准

年龄范围: 18 Years 至 —（Adult, Older Adult）
性别: All
接受健康志愿者: 否

入选标准

未提供

排除标准

未提供

结局指标

主要结局

Retained gastric food

时间窗: From time of enrollment until the end of surgery, assessed up to 4 weeks

Incidence of clinically significant retained gastric food, defined as visible solid/particulate matter, or liquid volume \> 1.5cc/kg

次要结局

Incidence of pulmonary aspiration event(From the time surgery begins until the end of scheduled surgery, assessed up to 24 hours)

研究者

发起方

Medical University of South Carolina

申办方类型

Other

责任方

Principal Investigator

主要研究者

Phillip Wilson

Principal Investigator/ Assistant Professor

Medical University of South Carolina

研究点 (1)

Loading locations...

相似试验

已完成

不适用

Evaluation of the Effects of a Biostimulator and Dermal Fillers for Cheek Augmentation and Contour DeficienciesWeight LossSkin LaxityPhotodamaged SkinVolume Deficiency of the MidfacePhotoaging

NCT06351358Galderma R&D41

已完成

不适用

DIabetes REsearCh on Patient sTratification (DIRECT): GLP-1R AgonistsDiabetes

NCT01575301University of Dundee411

已完成

不适用

Glucagon-like Peptide (GLP) Utilization and SafetyDiabetes Mellitus, Type 2

NCT01767389GlaxoSmithKline1

招募中

不适用

Glucagon-like Peptide 1 (GLP1) Receptor Agonists and Mental HealthMental Health IssueDiabetes MellitusObesity

NCT05492305King's College London20

招募中

不适用

Comparing effects of a long acting GLP-1 receptor agonist liraglutide with a short acting GLP-1 receptor agonist lixisenatide on diabetic cardiac autonomic neuropathy and glycemic variability evaluated by power spectral analysis of 24-hr heart rate and continuous glucose monitoring.Type 2 diabetes

JPRN-UMIN000017144Department of Endocrinology and Metabolism, Dokkyo Medical University30